文献速递产科

用于产后出血早期识别与管理以预防病率的新兴技术

Emerging technology for early detection and management of postpartum hemorrhage to prevent morbidity.
PubMed 文献 · Am J Obstet Gynecol MFM · 2022-09-06

产后出血仍是全球孕产妇死亡的首位原因,美国分娩当日及产后第一周出血亦为首位死因。目测估计失血量可低估多达40%,且失血量越大越不准确。本文综述用于产后出血早期准确识别及输血决策的新兴技术。

要点

  • 产后出血仍是全球孕产妇死亡首位原因,美国分娩当日及产后一周出血为首位死因。
  • 目测检查污染护垫、床单与剖腹海绵估计失血量可低估多达40%,失血越多越不准确。
  • 健康足月孕妇失血超过1 L前可借外周血管收缩代偿,血压显著下降与明显心动过速(>120 bpm)可能在失血达血容量30%至40%后才出现。

核心结论

  • 产后出血仍是全球孕产妇死亡的首位原因,美国分娩当日及产后第一周出血为首位死因,输血占分娩期及产后严重母体病率的很大比例。
  • 目测估计失血量可低估多达40%,且随失血量增加准确性更差;在资源匮乏环境中,生命体征异常出现与临床失代偿之间的窗口很窄,可能造成灾难性后果。
  • 一旦发现出血,输血决策常基于不准确的失血量估计,使患者面临复苏不足(增加失血性休克与终末器官损伤风险)或复苏过度(增加输血反应、液体超负荷与同种免疫风险)的风险。
  • 本文综述用于协助产后出血早期准确识别及输血决策的新兴技术。

研究设计与样本

  • 本文为综述,检索范围原文未报告。

主要发现

  • 目测检查污染护垫、床单与剖腹海绵估计失血量可低估多达40%,且随失血量增加而越来越不准确。
  • 年轻健康产科患者通过外周血管收缩代偿失血,在失血超过1 L前维持心率与血压在正常范围。
  • 血压显著下降伴明显心动过速(>120 bpm)可能在失血达血容量30%至40%、即健康足月孕妇2.0至2.6 L后才出现,此后患者可能迅速失代偿。
  • 一旦发现出血,输血决策常基于不准确的失血量估计,使患者面临复苏不足或复苏过度的风险。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite advances in hemorrhage detection and management, postpartum hemorrhage remains the single leading cause of maternal death worldwide. Within the United States, hemorrhage is the leading cause of maternal death on the day of delivery and within the first week after delivery. Blood transfusion after hemorrhage represents a large proportion of severe maternal morbidity during and after delivery. Blood loss during delivery has historically been assessed visually by inspecting soiled pads, linens, and laparotomy sponges. These methods underestimate the volume of blood loss by as much as 40%, becoming increasingly inaccurate as blood loss increases. Young, healthy obstetrical patients compensate for blood loss via peripheral vasoconstriction, maintaining heart rate and blood pressure in a normal range until over 1 L of blood has been lost. A significant decrease in blood pressure along with marked tachycardia (>120 bpm) may not be seen until 30% to 40% of blood volume has been lost, or 2.0 to 2.6 L in a healthy term pregnant patient, after which the patient may rapidly decompensate. In resource-poor settings especially, the narrow window between the emergence of significant vital sign abnormalities and clinical decompensation may prove catastrophic. Once hemorrhage is detected, decisions regarding blood product transfusion are routinely made on the basis of inaccurate estimates of blood loss, placing patients at risk of underresuscitation (increasing the risk of hemorrhagic shock and end-organ damage) or overresuscitation (increasing the risk of transfusion reaction, fluid overload, and alloimmunization). We will review novel technologies that have emerged to assist both in the early and accurate detection of postpartum hemorrhage and in decisions regarding blood product transfusion.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Lord MG, Calderon JA, Ahmadzia HK, et al. Emerging technology for early detection and management of postpartum hemorrhage to prevent morbidity. Am J Obstet Gynecol MFM. 2022. PMID: 36075527. doi:10.1016/j.ajogmf.2022.100742

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。